Skip to main content
メニュー
JP

Resource Center

Filters
Select resource types
Select products & services (1)
Select solutions (1)
Active Filters (2)
Clear All
1 - 12 of 23 Results
Sort by: Best Match
Best Match
Title A-Z
Title Z-A
Filter & Sort
Whitepaper Icon   Whitepaper
Accelerating immuno-oncology therapeutic development: choosing the best preclinical model
Selecting the appropriate preclinical model for immuno-oncology therapeutic development.
Whitepaper Icon   Whitepaper
Eyes on synaptotagmin 7 (SYT7) in synaptic function and neuroplastic health for cognitive decline
Researcher, Dr. Jason Vevea, describes the role of synaptotogmin 7 in the synaptic vesicle cycle and the experimental steps taken to discover that SYT7 supports asynchronous release, short-term synaptic plasticity, and synaptic vesicle replenishment.
Application Note Icon   Application Note
HTRF platform for anticancer drug discovery: from 2D and 3D cell cultures to xenograft models
Learn how to analyze cell signaling pathways on in vitro and in vivo sample types routinely used in the anticancer drug discovery process.
Application Note Icon   Application Note
Excellent sensitivity from the EnVision Nexus multimode plate reader for AlphaLISA detection
This application note demonstrates the AlphaLISA detection capabilities of the EnVision Nexus and compares it to the EnVision 2105.
Whitepaper Icon   Whitepaper
Complete gene therapy review in a single industry report
A single Industry Report in collaboration with Labiotech provides a complete review of gene therapy including market trends, current challenges and a glimpse to the future.
Application Note Icon   Application Note
Utilizing AlphaLISA technology to screen for inhibitors of the CTLA-4 immune checkpoint
In this Application Note, AlphaLISA® assays are used for screening novel CTLA-4 blocking drugs. Learn more.
Case Study Icon   Case Study
NIH NCATS case study: using accelerated screening research for SARS-CoV-2 drug repurposing candidates
Find out how the NCATS team was able to quickly screen 3,384 molecular entities and narrow them down to a field of 25 quality "hits" capable of disrupting SARS-Cov-2 S1 protein:ACE2 receptor binding in this case study.
Application Note Icon   Application Note
CDK signaling: Investigate CDK4/6 inhibition in breast cancer cell lines with HTRF immunoassays
Learn how to analyze the inhibition of CDK4 and CDK9 in breast cancer using no-wash immunoassays.
Infographic Icon   Infographic
Nonalcoholic fatty liver disease (NAFLD)
Explore this infographic on NAFLD, including facts on epidemiology and risk factors, development, and disease progression.
Guide Icon   Guide
Unlocking insights with AlphaLISA anti-drug antibodies detection assays
Unlock ADA insights with AlphaLISA technology.
Flyer Icon   Flyer
Reagent solutions for virology research
Discovery a range of immunoassays and other products Revvity offers to help you save time, increase your productivity in virology research.
Application Note Icon   Application Note
Advancing autophagy detection: HTRF LC3B-II assay for specific and reliable LC3B-II detection
This study validates the HTRF LC3B-II immunoassay as a reliable, precise, and faster alternative to the traditional LC3 Western Blot for quantifying autophagy in various cellular models.
resource-center-page-end-card-bg-illuminator.png
resource-center-page-end-card-bg-illuminator-mobile.png

Looking for technical documents?

Find the technical documents you need, ASAP, in our easy-to-search library.